Present status and strategy of NSAIDs-induced small bowel injury

Journal of Gastroenterology

Volumn 44, Issue 9, 2009, Pages 879-888

  Higuchi, Kazuhide ^a   Umegaki, Eiji ^a   Watanabe, Toshio ^b   Yoda, Yukiko ^a   Morita, Eijiro ^a   Murano, Mitsuyuki ^a   Tokioka, Satoshi ^a   Arakawa, Tetsuo ^b  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Anti ulcer drugs; Aspirin; Balloon enteroscopy; Capsule endoscopy; NSAID; Small intestinal injury

Indexed keywords

12 SULFODEHYDROABIETIC ACID; ACETYLSALICYLIC ACID; CALGRANULIN; CELECOXIB; CIMETIDINE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DICLOFENAC; EDETATE CHROMIUM CR 51; ETODOLAC; FAMOTIDINE; IRSOGLADINE MALEATE; LAFUTIDINE; LANSOPRAZOLE; MELOXICAM; METRONIDAZOLE; MISOPROSTOL; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PLACEBO; PROSTAGLANDIN DERIVATIVE; PROTON PUMP INHIBITOR; RABEPRAZOLE; REBAMIPIDE; ROXATIDINE; SALAZOSULFAPYRIDINE; SUCRALFATE; TEPRENONE; UNINDEXED DRUG;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; BLOATING; CAPSULE ENDOSCOPY; CONSTIPATION; DIARRHEA; DOSE RESPONSE; DOUBLE BALLOON ENTEROSCOPY; DRUG EFFICACY; DRUG MECHANISM; DRUG WITHDRAWAL; ENDOSCOPIC THERAPY; ENZYME INHIBITION; EPIGASTRIC PAIN; FECES ANALYSIS; GASTRODUODENAL ULCER; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL RADIOGRAPHY; GASTROINTESTINAL TRACT SCINTISCANNING; HUMAN; INTESTINAL BLEEDING; INTESTINE INJURY; INTESTINE MUCOSA PERMEABILITY; INTESTINE ULCER; LOW DRUG DOSE; NONHUMAN; PATHOGENESIS; PEPTIC ULCER; PRIORITY JOURNAL; REVIEW; SMALL INTESTINE MUCOSA; STOMACH ULCER;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTI-ULCER AGENTS; CLINICAL TRIALS AS TOPIC; HUMANS; INTESTINAL DISEASES; INTESTINAL MUCOSA; INTESTINE, SMALL;

EID: 70349651858     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-009-0102-2     Document Type: Review

References (81)

1. Allison MC, Howatson AG, Torrance CJ, Lee FD, Russell RI. Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. N Engl J Med. 1992;327(11):749-54.
2. Kameda N, Higuchi K, Shiba M, Machida H, Okazaki H, Yamagami H, et al. A prospective, single-blind trial comparing wireless capsule endoscopy and double-balloon enteroscopy in patients with obscure gastrointestinal bleeding. J Gastroenterol. 2008;43(6):434-40.
3. Yamamoto H, Sekine Y, Sato H, Higashizawa T, Miyata T, Iino S, et al. Total enteroscopy with a nonsurgical steerable double-balloon method. Gastrointest Endosc. 2001;53:216-20.
4. Sunada K, Yamamoto H. Double-balloon endoscopy: Past, present, and future. J Gastoronterol. 2009;44:1-12.
5. Bjarnason I, Price AB, Zanelli G, Smethurst P, Burke M, Gumpel JM, et al. Clinicopathological features of nonsteroidal anti-inflammatory drug-induced small intestinal strictures. Gastroenterology. 1988;94:1070-4.
6. Lang J, Price AB, Levi AJ, Burke M, Gumpel JM, Bjarnason I. Diaphragm disease: Pathology of disease of the small intestine induced by non-steroidal anti-inflammatory drugs. J Clin Pathol. 1988;41:516-26.
7. Matsuhashi N, Yamada A, Hiraishi M, Konishi T, Minota S, Saito T, et al. Multiple strictures of the small intestine after long-term non-steroidal anti-inflammatory drug therapy. Am J Gastroenterol. 1992;87:1183-6.
8. Fellows IW, Clarke JM, Roberts PF. Non-steroidal anti-inflammatory drug-induced jejuna and colonic diaphragm disease. A report of two cases. Gut. 1992;33:1424-6.
9. Morris AJ, Madhok R, Sturrock RD, Capell HA, MacKenzie JF. Enteroscopic diagnosis of small bowel ulceration in patients receiving non-steroidal anti-inflammatory drugs. Lancet. 1991;337:520.
10. Graham DY, Opekun AR, Willingham FF, Qureshi WA. Visible small-intestinal mucosal injury in chronic NSAID users. Clin Gastroenterol Hepatol. 2005;3(1):55-9.
11. Sugimori S, Watanabe T, Tabuchi M, Kameda N, Machida H, Okazaki H, et al. Evaluation of small bowel injury in patients with rheumatoid arthritis by capsule endoscopy: Effects of anti-rheumatoid arthritis drugs. Digestion. 2008;78:208-13.
12. Leung WK, Bjarnason I, Wong VW, sung JJ, Chan FK. Small bowel enteropathy associated with chronic low-dose aspirin therapy. Lancet. 2007;369:614.
13. Lengeling RW, Mitros FA, Brennan JA, Schulze KS. Ulcerative ileitis encountered at ileo-colonoscopy. Likely role of nonsteroidal agents. Clin Gastroenterol Hepatol. 2003;1:9-160.
14. Matsumoto T, Kudo T, Esaki M, Yano T, Yamamoto H, Sakamoto C, et al. Prevalence of non-steroidal anti-inflammatory drug-induced enteropathy determined by double-balloon endoscopy: A Japanese multicenter study. Scand J Gastroenterol. 2008;43:490-6.
15. Watanabe T, Sugimori S, Kameda N, Machida H, Okazaki H, Tanigawa T, et al. Small bowel injury by low-dose enteric-coated aspirin and treatment with misoprostol: A pilot study. Clin Gastroenterol Hepatol. 2008;6(11):1279-82.
16. Pilotto A, Seripa D, Franceschi M, Scarcelli C, Colaizzo D, Grandone E, et al. Genetic susceptibility to nonsteroidal anti-inflammatory drug-related gastroduodenal bleeding: Role of cytochrome P450 2C9 polymorphisms. Gastroenterology. 2007;133:465-71.
17. Kelly ME, McMahon LE, Jaroszewski DE, Yousfi MM, DePetris G, Swain JM. Small bowel diaphragm disease: Seven surgical cases. Arch Surg. 2005;140:22-1162.
18. Onwudike M, Sundaresan M, Melville D, Wood JJ. Diaphragm disease of the small-bowel: A case report and literature review. Did Surg. 2002;19:410-3.
19. Hayashi Y, Yamamoto H, Takauchi H, Sunada K, Miyata T, Yano T, et al. Nonsteroidal anti-inflammatory drug-induced small-bowel lesions indentified by double-balloon endoscopy: Endoscopic features of the lesions and endoscopic treatments for diaphragm disease. J Gastroenterol. 2009; 44 (Suppl XIX):57-63.
20. Robert A, Asano T. Resistance of germ-free rats to indomethacin-induced intestinal inflammation. Prostaglandins. 1977;14:333-41.
21. Fang WF, Broughton A, Jacobson ED. Indomethacin induced intestinal inflammation. Am J Dig Dis. 1977;22:749-60.
22. Whittle BJ. Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat. Gastroenterology. 1981;80:94-8.
23. Bjarnason I, Hayllar J, MacPherson AJ, Russell AS. Side effects of nonsteroidal anti-inflammatory drugs on the small intestine in humans. Gastroenterology. 1993;104:1832-47.
24. Yamada T, Deitch E, Specian RD, Perry MA, Sartor RB, Grisham MB. Mechanisms of acute and chronic intestinal inflammation induced by indomethacin. Inflammation. 1993;17:641-62.
25. Kunikata T, Araki H, Takeeda M, Kato S, Takeuchi K. Prostaglandin E prevents indomethacin-induced gastric and intestinal damage through EP receptor subtypes. J Physiol Paris. 2001;95:157-63.
26. Takeuchi K, Miyazawa T, Tanaka A, Kato S, Kunikata T. Pathogenic importance of intestinal hypermotility in NSAID-induced small intestinal damage in rats. Digestion. 2002;66:30-41.
27. Whittle BJR, Laszlo F, Evans SM, Moncada S. Induction of nitric oxide synthase and microvascular injury in the rat jejunum provoked by indomethacin. Br J Pharmacol. 1995;116:2286-90.
28. Konaka A, Tanaka A, Kato S, Nishijima M, Takeuchi K. Nitric oxide, superoxide radicals and mast cells in pathogenesis of indomethacin-induced intestinal lesions in rats. J Pharmacol Physiol. 1999;50:25-38.
29. Tanaka A, Kunihata T, Konaka A, et al. Dual action of nitric oxide in pathogenesis of indometachin-induced small intestinal ulceration in rats. J Physiol Pharmacol. 1999;50:405-17.
30. Boughton-Smith NK, Evans SM, Laszlo F, Whittle BJ, Moncada S. The induction of nitric oxide synthase and intestinal vascular permeability by endotoxin in the rat. Br J Pharmacol. 1993;110:1189-95.
31. Reuter BK, Davies NM, Wallace JL. Nonsteroidal anti-inflammatory drug enteropathy in rats: Role of permeability, bacteria, and enterohepatic circulation. Gastroenterology. 1997;112:109-17.
32. Watanabe T, Higuchi K, Kobata A, Nishio H, Tanigawa T, Shiba M, et al. Non-steroidal anti-inflammatory drug-induced small intestinal damage is Toll-like receptor 4 dependent. Gut. 2008;57:181-7.
33. Sigthorsson G, Simpson RJ, Walley M, Anthony A, Foster R, Hotz-Behoftsitz C, et al. COX-1 and 2, intestinal integrity, and pathogenesis of nonsteroidal anti-inflammatory drug enteropathy in mice. Gastroenterology. 2002;122:1913-23.
34. Ligumsky M, Golanska EM, Hansen DG, Kauffman GL. Aspirin can inhibit gastric mucosa cyclo-oxygenase without causing lesions in rat. Gastroenterology. 1983;84:756-61.
35. Takeuchi K, Hase S, Mizoguchi H, Komoike Y, Tanaka A. Protection by aspirin of indomethacin-induced small intestinal damage in rats. Mediation by salicylic acid. J Physiol Paris. 2001;95:51-7.
36. Tibble JA, Sigthorson G, Foster R, Scott D, Fagerhol MK, Roseth A, et al. High prevalence of NSAID enteropathy as shown by a simple faecal test. Gut. 1999;45:362-6.
37. Bjarnason I, Smethurst P, Fenn CG, Lee CE, Menzies IS, Levi AJ, et al. Misoprostol reduces indomethacin-induced changes in human small intestinal permeability. Dig Dis Sci. 1989;34:407-11.
38. Davies GR, Rampton DS. The pro-drug sulindac may reduce the risk of intestinal damage associated with the use of conventional non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther. 1991;5:593-8.
39. Aabakken I, Osnes M. 51 Cr-Ethylenediaminetetraacetic acid absorption test. Effects of naproxen, a non-steroidal, anti-inflammatory drug. Scand J Gastroenterol. 1990;25:917-24.
40. Bjarnason I, Zanelli G, Smith T, Orouse P, Williams P, DeLacey G, et al. Nonsteroidal anti-inflammatory drug induced intestinal inflammation in humans. Gastroenterology. 1987;93:480-9.
41. Yen HH, Chen YY, Soon MS. Non-steroidal anti-inflammatory drug-associated ileal ulcers: An evaluation by double-balloon enteroscopy. Gastrointest Endosc. 2006;63:328.
42. Hayashi Y, Yamamoto H, Kita H, Sunada K, Sato H, Yano Y, et al. Non-steroidal anti-inflammatory drug-induced small bowel injuries identified by double-balloon endoscopy. World J Gastroenterol. 2003;11:4861-4.
43. Kamata Y, Iwamoto M, Nara H, Kamimura T, Takayashiki N, Yamamoto H, et al. A case of rheumatoid arthritis with protein losing enteropathy induced by multiple diaphragmatic stricture of the small intestine. Successful treatment by bougieing under double-balloon enteroscopy. Gut. 2006;55:1372.
44. Maiden L, Thjodleifsson B, Theodors A, Gonzalez J, Bjarnason I. A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy. Gastroenterology. 2005;128:1172-8.
45. Bjarnason I, Hayllar J, Smethurst P, Price A, Gumpel MJ. Metronidazole reduces intestinal inflammation and blood loss in non-steroidal anti-inflammatory drug induced enteropathy. Gut. 1992;33:1204-8.
46. Hayllar J, Smith T, Macpherson A, Price AB, Gumpel M, Bjarnason I. Nonsteroidal anti-inflammatory drug-induced small intestinal inflammation and blood loss: Effects of sulfasalazine and other disease-modifying antirheumatic drugs. Arthritis Rheum. 1994;37:1146-50.
47. Morris AJ, Murray L, Sturrock RD, et al. Short report: The effect of misoprostol on the anaemia of NSAID enteropathy. Aliment Pharmacol Ther. 1994;8:343-6.
48. Hawkey CJ, Karrasch JA, Szczepaňski L, Walker DG, Barkun A, Swannell AJ. et al. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal anti-inflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) study Group. N Engl J Med. 1998;338:727-34.
49. Yoda Y, Takeuchi K, Kato S, Amagase K, Umegaki E, Tokioka S, et al. Search for Prophylactic Drugs against NSAID-Induced small Intestinal lesions in Rats. Gastroenterology 2008;134(4):sUpplement 1, A-528.
50. Higuchi K, Watanabe T, Tominaga K, Shiba M, Nakagawa K, et al. Lafutidine can improve the quality of gastric ulcer healing in humans: A randomized controlled multicenter trial. Inflammopharmacology. 2006;14(5-6):226-30.
51. Müller P, Jackisch P, Simon B. Comparison of the protective effects of roxatidine and misoprostol on diclofenac gastroduodenal pathology. An endoscopic, controlled study of volunteers. Arzneimittelforschung. 1994;44:1127-9.
52. Suemasu S, Tanaka KI, Namba T, Ishihara T, Katsu T, Fujimoto M, Adachi H, Sobue G, Takeuchi K, Nakai A, Mizushima T. A role for HSP70 in protecting against indomethacin-induced gastric lesions. J Biol Chem. 2009 May 13. [Epub ahead of print].
53. Park SH, Cho CS, Lee OY, Jun JB, Lin SR, Zhou LY, et al. Comparison of prevention of NSAID-induced gastrointestinal complications by rebamipide and misoprostol: A randomized, multicenter, controlled trial-STORM. Clin Biochem Nutr. 2007;40(2):148-55.
54. Zhang X, Tajima K, Kageyama K, Kyoi T. Irsogladine maleate suppresses indomethacin-induced elevation of proinflammatory cytokines and gastric injury in rats. World J Gastroentrol. 2008;14(30):4784-90.
55. Koizumi W, Tanabe S, Imaizumi H, Kida M, Ohida M, Koshida Y, et al. Inhibition of peptic ulcer relapse by ranitidine and ecabet independently of eradication of Helicobactor pylori: A prospective, controlled study versus ranitidine. HepatoGastroenterology. 2003;50:577-81.
56. Kato S, Tanaka A, Kunikata T, Umeda M, Takeuchi K. Protective effect of lafutidin against indometacin-induced intestinal ulceration in rats: relation to capsaicin-sensitive sensory neurons. Digestion. 2000;61:39-46.
57. Kamei K, Kubo Y, Kato N, Hatazawa R, Amagase K, Takeuchi K. Prophylactic effect of irsogladine maleate against indomethacin-induced small intestinal lesions in rats. Dig Dis Sci. 2008;53(10):2657-66.
58. Fukuda T, Arakawa T, Shimizu Y, Ohtani K, Higuchi K, Kobayashi K. Effects of lansoprazole on ethanol-induced injury and PG synthetic activity in rat gastric mucosa. J Clin Gastroenterol. 1995;20(Suppl 2):S5-7.
59. Natale G, Lazzeri G, Lubrano V, Colucci R, Vassalle C, Fornai M, et al. Mechanisms of gastroprotection by lansoprazole pretreatment against experimentally induced injury in rats: Role of mucosal oxidative damage and sulfhydryl compounds. Toxicol Appl Pharmacol. 2004;195:1710-5.
60. Fornai M, Natale G, Colucci R, Tuccori M, Carazzina G, Antonioli L, et al. Mechanisms of protection by pantoprazole against NSAID-induced gastric mucosal damage. Naunyn Schmiedebergs Arch Pharmacol. 2005;372:79-87.
61. Wandall JH. Effect of omeprazole on neutrophil chemotaxis, super oxide production, degranulation and translocation of cytochrome b-245. Gut. 1992;33:617-21.
62. Yoshida N, Yoshikawa T, Tanaka Y, Fujita N, Kassai K, Naito Y, et al. A new mechanism for anti-inflammatory actions of proton pump inhibitors-inhibitory effects on neutrophil-endothelial cell interactions. Aliment Pharmacol Ther. 2000;14(Suppl 1):74-81.
63. Biswas K, Bandyopadhyay U, Chattopadhyay I, Varadaraj A, Ali E, Banerjee RK. A novel antioxidant and antiapoptotic role of omeprazole to block gastric ulcer through scavenging of hydroxyl radical. J Biol Chem. 2003;278:10993-1001.
64. Kuroda M, Yoshida N, Ichikawa H, Takagi T, Okuda T, Naito Y, et al. Lansoprazole, a proton pump inhibitor, reduces the severity of indomethacin-induced rat enteritis. Int J Mol Med. 2006;17:89-93.
65. Pozzoli C, Menozzi A, Grandi D, Solenghi E, Ossiprandi MC, Zullian C, et al. Protective effects of proton pump inhibitors against indomethacin-induced lesions in the rat small intestine. Naunyn-Schmiedebergs Arch Pharmacol. 2007;374:283-91.
66. Becker JC, Grosser N, Waltke C, Schulz S, Erdmann K, Domschke W, et al. Beyond gastric acid reduction: Proton pump inhibitors induce heme oxygenase-1 in gastric and endothelial cells. Biochem Biophys Res Commun. 2006;345(3):1014-21.
67. Yoda Y, Higuchi K, Takeuchi K, et al. Proton pump inhibitor (PPI), lansoprazole prevents indomethacin-induced small intestinal ulceration in rats: Involvement of Heme Oxygenase (HO)-1. Gastroenterology. 2009;136(5): Supplement 1.A-684.
68. Goldstein JL, Eisen GM, Lewis B, Gralnek IM, Zlotnick S, Fort JG, Investigators. Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo. Clin Gastroenterol Hepatol. 2005;3:133-41.
69. Niwa Y, Nakamura M, Ohmiya N, Maeda O, Ando T, Itoh A, et al. Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects: A prospective, randomized, double-blinded, placebo-controlled, cross-over study. J Gastroenterol. 2008;43(4):270-6.
70. Fujimori S, Seo T, Gudis K, Ehara A, Kobayashi T, Mitsui K, et al. Prevention of nonsteroidal anti-inflammatory drug-induced small-intestinal injury by prostaglandin: A pilot randomized controlled trial evaluated by capsule endoscopy. Gastrointest Endosc. 2009;69(7):1339-46.
71. Maiden L, Yhjodleifssion B, Seigal A, Bjarnason II, Scott D, Brigisson S, et al. Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel; a cross-sectional capsule enteroscopy study. Clin Gastroenterol Hepatol. 2007;5:1040-5.
72. Maiden L. Capsule endoscopic diagnosis of nonsteroidal antiinflammatory drug-induces enteropathy. J Gastroenterol 2009; 44(suppl 19):64-71.
73. Vane JR. Towards a better aspirin. Nature. 1994;367:215-6.
74. Vane JR, Botting RM. Mechanism of action of anti-inflammatory drugs. Scand J Rheumatol Suppl. 1996;102:9-21.
75. Sigthorsson G, Simpson RJ, Wally M, Anthony A, Foster R, Hotz-Behoftsiz C, et al. COX-1 and 2, intestinal integrity, and pathogenesis of nonsteroidal anti-inflammatory drug enteropathy in mice. Gastroenterogy. 2002;122:1913-23.
76. Langenbach R, Morham SG, Tiano HF, Loftin CD, Ghanayem BI, Chulada PC, et al. Prostaglandin synthase I gene disruption in mice reduced arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell. 1995;83:483-92.
77. Wallance JL, McKnight W, Reuter BK, et al. NSAID-induced gastric damage in rats: Requirement for inhibition of both cyclooxygenase 1 and 2. Gastroenterology. 2000;119:706-14.
78. Mitchell J, Evens T. Cyclooxygenase-2 as a therapeutic target. Inflamm Res. 1998;47(suppl 2):S88-92.
79. Matsumoto T, Iida M, Matsui T, Yao T, Watanabe H, Okabe H. Non-specific multiple ulcers of the small intestine unrelated to non-steroidal anti-inflammatory drugs. J Clin Pathol. 2004;57:1145-50.
80. Mehdizadch S, Lo SK. Treatment of small-bowel diaphragm disease by using double-balloon enteroscopy. Gastrointest Endosc. 2006;64:1014-7.
81. Tanaka S, Mitsui K, Shirakawa K, Tatsuguchi A, Nakamura T, Hayashi Y, et al. Successful retrieval of video capsule endoscopy retained at ileal stenosis of Crohn's disease using double-balloon endoscopy. J Gastroenterol Hepatol. 2006;21:922-3.